
NASDAQHealthcareMedical - Care Facilities
最新資料
US$9.52
+US$0.11 · +1.17%
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
前收盤價
US$9.52
+US$0.11 · +1.17%
盤中時間採用ET。市場資料可能有所延遲。
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
日內區間
目前US$9.52
52週區間
目前US$9.52
盤中時間採用ET。市場資料可能有所延遲。
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
日內區間
目前US$9.52
52週區間
目前US$9.52
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 2.7億 USD | 2.24億 USD | 1.83億 USD | 1.39億 USD | 1.17億 USD |
| 銷貨成本 | 1.15億 USD | 9105.4萬 USD | 7022.5萬 USD | 5415.2萬 USD | 4365.2萬 USD |
| 毛利 | 1.55億 USD | 1.33億 USD | 1.13億 USD | 8468萬 USD | 7341萬 USD |
| 研究與開發 | 301.7萬 USD | 306.8萬 USD | 278.2萬 USD | 269.6萬 USD | 211萬 USD |
| 銷售、一般及管理費用 | 1.3億 USD | 1.12億 USD | 9373.3萬 USD | 7336.3萬 USD | 6004.3萬 USD |
| 營業費用 | 1.35億 USD | 1.15億 USD | 9845.3萬 USD | 7642.8萬 USD | 6183萬 USD |
| 利息支出 | 118.2萬 USD | 77.6萬 USD | 42.4萬 USD | 19.7萬 USD | 31.8萬 USD |
| 折舊和攤銷 | 2861.3萬 USD | 2536.8萬 USD | 2186.2萬 USD | 1563萬 USD | 1131.2萬 USD |
| 營業利益 | 2071萬 USD | 1790萬 USD | 1433萬 USD | 825.2萬 USD | 1158萬 USD |
| 淨利 | 1493.4萬 USD | 1126.5萬 USD | 1024.3萬 USD | 622.2萬 USD | 912.6萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$14.00
上漲空間 47.06%報告持有此股票曝險的交易所交易基金。
iShares Russell 2000 ETFIWM836.59萬0.01%787.4億 USD0.19%US$278.94+0.49%
Vanguard Morningstar Total Stock Market ETFVTI806.84萬0.00%2.3兆 USD0.03%US$381.94+0.63%
Vanguard Extended Market ETFVXF346.2萬0.00%954億 USD0.05%US$235+0.80%
iShares Russell 2000 Growth ETFIWO299.93萬0.02%139.17億 USD0.24%US$356.78+0.94%
Vanguard Russell 2000 ETFVTWO172.89萬0.01%180億 USD0.06%US$112.66+0.50%
iShares Micro-Cap ETFIWC101.24萬0.08%13.17億 USD0.60%US$183+0.11%
Vanguard Russell 2000 Growth ETFVTWG32.56萬0.02%17億 USD0.06%US$260.49+0.91%
Invesco RAFI US 1500 Small-Mid ETFPRFZ23.28萬0.01%26.7億 USD0.36%US$53.16+0.64%
iShares Russell 2000 ETFIWM
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
Vanguard Russell 2000 ETFVTWO
iShares Micro-Cap ETFIWC
Vanguard Russell 2000 Growth ETFVTWG
Invesco RAFI US 1500 Small-Mid ETFPRFZAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。